Table 2 —

Prevalence of the metabolic syndrome and the different components of the metabolic syndrome* in male and female subjects of different age decades with NGT, abnormal IFG/IGT, and diabetic glucose tolerance

NGT
IFG/IGT
Type 2 diabetes
MaleFemaleMaleFemaleMaleFemale
Metablic syndrome
 all 35–70 years151064428478
 40–49 years12659388778
 50–59 years20967448374
 60–69 years201966528481
Obesity
 all 35–70 years763686519278
 40–49 years763487499580
 50–59 years813286569379
 60–69 years804489539278
Dyslipidemia
 all 35–70 years291645315456
 40–49 years311351256664
 50–59 years281746315551
 60–69 years2321393750§57
Hypertension
 all 35–70 years232431355559
 40–49 years201719314247
 50–59 years272941345553
 60–69 years354139§4759§67
Microalbuminuria
 all 35–70 years43762212
 40–49 years34161418
 50–59 years32881912
 60–69 years81992611
Insulin resistance
 all 35–70 years252558598789
 40–49 years231953528789
 50–59 years282465578789
 60–69 years293559688690
  • Data are %.

  • *

    * The definition of the metabolic syndrome was based on the recent WHO proposal (17);

  • P < 0.001 for differences in all variables between subjects with diabetes and NGT/IFG/IGT when men and women aged 35–70 years were compared separately;

  • P < 0.05;

  • §

    § P < 0.01;

  • P < 0.001 when age decade 60–69 was compared to age decade 40–49;

  • highest quartile of HOMAIR.